Skip to main content

Moderna

Moderna Inc is an American biotechnology company pioneering messenger RNA therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune conditions. The company utilizes its proprietary mRNA platform and lipid nanoparticle delivery technology to instruct human cells to produce therapeutic proteins and target antigens. Its commercial portfolio features mRNA COVID-19 vaccines and respiratory syncytial virus vaccines, alongside a pipeline of investigational vaccines for influenza, cytomegalovirus, and personalized cancer treatments. Principal revenue is generated through product sales of mRNA vaccines, upfront licensing milestone payments, and government research grant funding. Moderna occupies a leading global position in mRNA biotechnology, supported by large-scale manufacturing facilities and global supply agreements. Headquartered in Cambridge, Massachusetts, the company's common stock is publicly listed and traded on the Nasdaq Global Select Market under the ticker MRNA.

10 of the funds FundTelligence covers report a position in Moderna.

Legal name
Moderna Inc
Sector
Health Care
Country
United States
Funds holding it
10

Funds holding Moderna

Showing the 8 largest of 10 funds holding it.

Loading...